Status:
RECRUITING
Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Tricuspid Valve Regurgitation; Complications, Longterm Outcome
Eligibility:
All Genders
16+ years
Brief Summary
This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.
Eligibility Criteria
Inclusion
- patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery
Exclusion
- age \<16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.
Key Trial Info
Start Date :
January 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT06554119
Start Date
January 1 1999
End Date
January 1 2025
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University
Guangzhou, Guangdong, China, 510080